Aster Guardians Global Nursing Award Unveils Top 10 Finalists for 2025 from 100,000+ Registrations Aster DM May 08, 2025 16:54 HKT/SGT Read More
Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China Everest Medicines Limited May 07, 2025 18:06 HKT/SGT Read More
Global Survey Reveals Urgent Gaps in Awareness, Access, and Treatment for Hepatitis D World Hepatitis Alliance May 06, 2025 20:00 HKT/SGT Read More
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards Northway Biotech May 05, 2025 19:30 HKT/SGT Read More
Eisai Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star Eisai Apr 30, 2025 13:17 HKT/SGT Read More
Azurite Medical and Wellness Launches Revolutionary Luxury Surgical Retreat Concept in Global Medical Tourism Market Pressmaster DMCC Apr 29, 2025 02:09 HKT/SGT Read More
汇聚科技有限公司公布截至二零二四年十二月三十一日止末期业绩 TIME Interconnect Technology Limited Apr 25, 2025 17:41 HKT/SGT Read More
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia Coya Therapeutics, Inc. Apr 25, 2025 15:49 HKT/SGT Read More
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025 HighTide Therapeutics Inc. Apr 24, 2025 18:43 HKT/SGT Read More
A Decade of Olympus India's Commitment to Community Welfare Olympus Apr 22, 2025 12:00 HKT/SGT Read More
Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union Eisai Apr 18, 2025 15:52 HKT/SGT Read More
analytica Vietnam 2025 Concludes with Record-Breaking Attendance and Exhibitor Participation MMI Asia Pte Ltd (MMI) Apr 16, 2025 23:55 HKT/SGT Read More
エーザイとバイオジェン、「レケンビ」(レカネマブ)が欧州連合(EU)において早期アルツハイマー病の進行を抑制する初めての治療剤として承認を取得 Eisai Apr 16, 2025 11:30 JST Read More